Stem Cell Therapy for Autism Part 2
He is a known case of Autism with history of full term caesarean section delivery and cried immediately after birth with near normal motor milestones. But as he was put in school, there were regular complaints of him being hyperactive. He was then diagnosed to have Autism. He was shifted to special school then. Neurologically, he has near normal tone, reflexes and muscle power. On examination: he has hyperactivity. He has aggressive behaviour with episodes of violence and beating others. He has repetitive speech (echolalia), but it is need based. He has social isolation. He is bowel bladder trained. He is independent in most ADL. Functionally, he needs supervision in most ADL. On FIM he scores 106. After Stem Cell Therapy Psychology assessment: 1) Now his duration of expressing his anger has reduced (ie) previously he would get angry and it would continue for half an hour to 20 minutes. Now it has reduced to 10 minutes. 2) Now his level of understanding and tolerance level has increased (ie) before he would get upset even before his parents spoke whereas now he listens to them and follows commands. 3) Now he has started writing (ie) now he can copy from the book and he can do so for a duration of ½ hour to 1 hour which wasn #39;t possible at all before. 4) Previously he had obsessive features like washing his hands repetitively but now it has reduced. 5) Previously he would disturb others in the classroom by shouting or sitting next to them but now he doesn #39;t disturb others ...

By: neurogenbsi

Go here to read the rest:
Stem Cell Therapy for Autism Part 2 - Video

Recommendation and review posted by Bethany Smith

SALT LAKE CITY, Feb. 28, 2013 /PRNewswire/ --Discgenics announces the successful completion of an animal study demonstrating safety and efficacy of its novel therapy for reducing back pain caused by degenerative disc disease. This product, known as Injectable Discosphere Cell Therapy (IDCT), features Discgenics' patented, allogeneic, human disc-derived stem cell technology. The study showed that after one injection of IDCT in degenerated discs there was a restoration of disc height and tissue architecture, while noting no inflammatory response.

Discgenics CEO Flagg Flanagan said, " We are very encouraged by the results of the small animal pilot study as it shows the initial safety and efficacy of IDCT, which is produced from adult human disc-derived stem cells.We are optimistic that these early results will be indicative of our therapy's performance in further animal studies and will accelerate us toward human clinical studies and, ultimately, to an FDA cleared product.We believe this technology will revolutionize the way back pain is treated." Discgenics is currently conducting further studies of safety and efficacy in multiple animal species to support future scientific publications and for use in gaining regulatory clearance.

About Discgenics, Inc.

Discgenics is a privately funded spinal therapeutics company that is utilizing adult human disc stem cells within a tissue engineering approach to treat patients debilitated by degenerative disc disease. News and other information on the company are available at: http://www.discgenics.com.

Read more:
Discgenics Successfully Completes Pilot Efficacy Study of Injectable Discosphereâ„¢ Cell Therapy

Recommendation and review posted by Bethany Smith

Prof. Jean-Marie Lehn at MU part 2
Nobel Laureate for Chemistry Prof. Jean-Marie Lehn #39;s lecture and dialogue "Supramolecular chemistry: Contributions to biotechnology and nanotechnology" on Friday, January 7, 2005 at the National Genetic Engineering and Biotechnology Center (BIOTEC) of the Ministry of Science and Technology at the Thailand Science Park, Rangsit

By: PeaceFoundationNET

See original here:
Prof. Jean-Marie Lehn at MU part 2 - Video

Recommendation and review posted by Bethany Smith

Prof. Jean-Marie Lehn at MU part 1
Nobel Laureate for Chemistry Prof. Jean-Marie Lehn #39;s lecture and dialogue "Supramolecular chemistry: Contributions to biotechnology and nanotechnology" on Friday, January 7, 2005 at the National Genetic Engineering and Biotechnology Center (BIOTEC) of the Ministry of Science and Technology at the Thailand Science Park, Rangsit

By: PeaceFoundationNET

Read the original:
Prof. Jean-Marie Lehn at MU part 1 - Video

Recommendation and review posted by Bethany Smith

Champion Drive Genetics - 2013 Sire Line-Up
Champion Drive Genetics - 2013 Sire Line-Up - created at animoto.com

By: diamondgcattleco

Read the rest here:
Champion Drive Genetics - 2013 Sire Line-Up - Video

Recommendation and review posted by Bethany Smith

DoNUT Genetics
THIS VIDEO IS DETICATED TO THE FOLLOWING (in alphabetical order)~ Chestersee D-trix of theDOMINICshow Grace Helbig of My Damn Channel Hannah Hart of My Drunk Kitchen Jenna Marbles Mamrie Hart of You Deserve a Drink MaxNoSleeves Ryan Higa of HigaTV, and nigahiga + many more Swoozie06 SO PLEASE!!! Watch it!! First video! Please bear with us Please please please watch it all the way through!!! Comments and subscriptions and kind criticism would be deeply appreciated. this was a video Conceived of and made within 2 hours. I #39;m sure you understand. PLEASE NOTE - We did not tag these youtube celebs for views/subscribers. We just love them very much and wanted them to see (and hopefully love) this video. THANK YOU SOOOO MUCH FOR WATCHING OUR AMATEURISHNESS!

By: AprilRosyChampagne59

Follow this link:
DoNUT Genetics - Video

Recommendation and review posted by Bethany Smith

Diabetes: What is it and how did I get it?
Dr. Kotansis understands that every patient has a unique set of symptoms, conditions, circumstances and needs. He will listen, investigate your history and research the interactions in your genetics, environment, lifestyle, and diet.

By: TheKotsanisInstitute

See original here:
Diabetes: What is it and how did I get it? - Video

Recommendation and review posted by Bethany Smith

10 Amazing Facts About Fungi
A fungus (pron.: / #712;f #652; #331; #609; #601;s/; plural: fungi[3] or funguses[4]) is a member of a large group of eukaryotic organisms that includes microorganisms such as yeasts and molds (British English: moulds), as well as the more familiar mushrooms. These organisms are classified as a kingdom, Fungi, which is separate from plants, animals, and bacteria. One major difference is that fungal cells have cell walls that contain chitin, unlike the cell walls of plants, which contain cellulose. These and other differences show that the fungi form a single group of related organisms, named the Eumycota (true fungi or Eumycetes), that share a common ancestor (a monophyletic group). This fungal group is distinct from the structurally similar myxomycetes (slime molds) and oomycetes (water molds). The discipline of biology devoted to the study of fungi is known as mycology (from the Greek mu; #973; kappa; eta; sigmaf;, muk #275;s, meaning "fungus"). Mycology has often been regarded as a branch of botany, even though it is a separate kingdom in biological taxonomy. Genetic studies have shown that fungi are more closely related to animals than to plants. Abundant worldwide, most fungi are inconspicuous because of the small size of their structures, and their cryptic lifestyles in soil, on dead matter, and as symbionts of plants, animals, or other fungi. They may become noticeable when fruiting, either as mushrooms or molds. Fungi perform an essential role in the decomposition of organic matter and have fundamental roles in ...

By: MovieMania1506

Excerpt from:
10 Amazing Facts About Fungi - Video

Recommendation and review posted by Bethany Smith

Why was Gregor Mendel Ignored? Genetics in the 1800s - DP 2.7 Blueprint of Life HSC Biology
The reasons of why Robert Mendel was ignored and not taken seriously in the 1800s for his experiments on heredity. This is a quick overview for HSC students studying dot point 2.7 of the blueprint of life syllabus

By: hscbiologyexposed

Continue reading here:
Why was Gregor Mendel Ignored? Genetics in the 1800s - DP 2.7 Blueprint of Life HSC Biology - Video

Recommendation and review posted by Bethany Smith

BJORN HEYHEIM
Innovative solutions in genomics applications for sea bass and sea bream Athens, Greece, 11th October 2012 INTRANEMMA - MARINE GENOMICS for USERS Salmon aquaculture in Norway, breeding and genomics Bjørn Høyheim Norwegian School of Veterinary Science Department for Basic Sciences and Aquatic Medicine, Section for Genetics http://www.intranemma.eu

By: intranemma

Go here to see the original:
BJORN HEYHEIM - Video

Recommendation and review posted by Bethany Smith

Pedigree Charts
A simple description of how to create a pedigree chart in genetics.

By: Jennifer DesRochers

More:
Pedigree Charts - Video

Recommendation and review posted by Bethany Smith

LASER GENETICS DESIGNATOR ND3x50
I created this video with the YouTube Video Editor (www.youtube.com

By: erison bmx

View original post here:
LASER GENETICS DESIGNATOR ND3x50 - Video

Recommendation and review posted by Bethany Smith

Mandala Seeds : "Point Of No Return" *Cannabis Grow* Day 60 of Flower
Just flushed with distilled water. Will harvest in 7-10 days. This was the mother plant I started from seed anddecided to flower because the genetics of clones were superior in quality and growth characteristics. I Highly Recommend Mandala Seeds! Point of No Return Type: indica/sativa Genetics: Afghanistan; Mexico Cultivation: indoor/outdoor/greenhouse THC: 15,5%, CBD: 0,5% High: Predominantly knockout medical-grade indica stone; couch lock; body relaxation. Aroma: Peppermint; sweet; fruity-berry; maracuja. Medical use: Deep and long lasting medical effects; suitable for pain relief, reducing MS related spasms, hyperactivity nervousness, anxiety, stress related symptoms, sleep disorders, menstrual cramps, muscle relaxant. Flowering time outdoor: mid-October (south), late October (north) Flowering time indoor: 65-72 days Recommended light intensity: 400-600W HPS/m2 Yield (dry weight): 350-400 gr/m2; 100+ gr. per plant in greenhouse; 700-1000 gr. per plant outdoor in the ground. Plant Height: medium Detailed Description: This exceptional medical strain should not be missing in any garden if you are looking for a one-hit wonder with a good yield and delicious aroma. Point of No Return (PNR) delivers a beautiful crop of thick cone-shaped buds crowned by towers of resiny calyxes. The long head bud tapers at the end like a peak and has a sufficiently airy structure that contributes to the high mold resistance. Although this is not a large plant it focuses a tremendous amount ...

By: rockyta21

Read more:
Mandala Seeds : "Point Of No Return" *Cannabis Grow* Day 60 of Flower - Video

Recommendation and review posted by Bethany Smith

Lot 12 1215 full brother
Homestead Genetics Bull Sale March 30 2013, full brother to Lot 12

By: Summerrain411

More here:
Lot 12 1215 full brother - Video

Recommendation and review posted by Bethany Smith

Lot 12 20120209044053
Homestead Genetics Bull Sale March 30 2013, yearling heifer

By: Summerrain411

Read the original:
Lot 12 20120209044053 - Video

Recommendation and review posted by Bethany Smith

Vlad #39;s Grow Titan Genetics: Dawg #39;s Breath Ep. 3
Test grow for Titan Genetics: (Stardawg x Alien Kush f2) X Tennesee Hawg #39;s Breath Culled a couple and sexing the rest in cups.

By: Vladamyr

Read more here:
Vlad's Grow Titan Genetics: Dawg's Breath Ep. 3 - Video

Recommendation and review posted by Bethany Smith

WASHINGTON, March 1, 2013 /PRNewswire-USNewswire/ --Family Research Council (FRC) Senior Fellow Dr. David Prentice, a native Kansan, congratulated the Kansas state senate for passing S.B. 199, a bill that would establish the Midwest Stem Cell Therapy Center, a regional hub to advance and deliver adult and cord blood stem cell therapies to patients and serving as a resource for adult and cord blood stem cells for therapies. The Center would also inform professionals and the public about such therapies.

(Logo: http://photos.prnewswire.com/prnh/20080930/FRCLOGO)

Dr. Prentice, a cell biologist who was selected by George W. Bush's Council on Bioethics to write a comprehensive review of adult stem cell research in 2004, testified before the Kansas Senate Committee on Public Health and Welfare in support of S.B. 199 on Feb. 25. Dr. Prentice additionally serves as adjunct professor of molecular genetics at the John Paul II Institute at the Catholic University of America, and formerly served as professor of life sciences at Indiana State University and adjunct professor of medical and molecular genetic at Indiana University School of Medicine.

The bill will now go to the Kansas House of Representatives for consideration.

In his testimony Dr. Prentice said:

"There are significant opportunities right now for Kansas to benefit from the establishment of a center of excellence specializing in the application of adult stem cell therapies for certain diseases, as well as educating physicians as well as the public about the advantages and availability of stem cell treatments.

"Kansas is moving forward as a potential leader in the area of adult and cord blood stem cell therapies. Estimates are that KU Med has done over 1,000 adult stem cell transplants, from bone marrow as well as a growing number from umbilical cord blood. These include stem cell transplants for various cancers and leukemias, but also initiating clinical trials to treat heart damage. Much more is possible.

"Kansas is well-positioned to become a leader in this area, and a global resource. The potential benefits for patients are incalculable. I urge you to support S.B. 199."

To read Dr. Prentice's testimony, click here: http://www.frc.org/testimony/testimony-of-dr-david-prentice-before-the-committee-on-public-health-and-welfare-kansas-senate

SOURCE Family Research Council

Read this article:
FRC's Dr. David Prentice Congratulates Kansas Senate for Passing Ethical Stem Cell Therapy Bill

Recommendation and review posted by simmons

WASHINGTON, March 1, 2013 /PRNewswire-USNewswire/ --Family Research Council (FRC) Senior Fellow Dr. David Prentice, a native Kansan, congratulated the Kansas state senate for passing S.B. 199, a bill that would establish the Midwest Stem Cell Therapy Center, a regional hub to advance and deliver adult and cord blood stem cell therapies to patients and serving as a resource for adult and cord blood stem cells for therapies. The Center would also inform professionals and the public about such therapies.

(Logo: http://photos.prnewswire.com/prnh/20080930/FRCLOGO)

Dr. Prentice, a cell biologist who was selected by George W. Bush's Council on Bioethics to write a comprehensive review of adult stem cell research in 2004, testified before the Kansas Senate Committee on Public Health and Welfare in support of S.B. 199 on Feb. 25. Dr. Prentice additionally serves as adjunct professor of molecular genetics at the John Paul II Institute at the Catholic University of America, and formerly served as professor of life sciences at Indiana State University and adjunct professor of medical and molecular genetic at Indiana University School of Medicine.

The bill will now go to the Kansas House of Representatives for consideration.

In his testimony Dr. Prentice said:

"There are significant opportunities right now for Kansas to benefit from the establishment of a center of excellence specializing in the application of adult stem cell therapies for certain diseases, as well as educating physicians as well as the public about the advantages and availability of stem cell treatments.

"Kansas is moving forward as a potential leader in the area of adult and cord blood stem cell therapies. Estimates are that KU Med has done over 1,000 adult stem cell transplants, from bone marrow as well as a growing number from umbilical cord blood. These include stem cell transplants for various cancers and leukemias, but also initiating clinical trials to treat heart damage. Much more is possible.

"Kansas is well-positioned to become a leader in this area, and a global resource. The potential benefits for patients are incalculable. I urge you to support S.B. 199."

To read Dr. Prentice's testimony, click here: http://www.frc.org/testimony/testimony-of-dr-david-prentice-before-the-committee-on-public-health-and-welfare-kansas-senate

SOURCE Family Research Council

Read the original:
FRC's Dr. David Prentice Congratulates Kansas Senate for Passing Ethical Stem Cell Therapy Bill

Recommendation and review posted by Bethany Smith

SALT LAKE CITY, Feb. 28, 2013 /PRNewswire/ --Discgenics announces the successful completion of an animal study demonstrating safety and efficacy of its novel therapy for reducing back pain caused by degenerative disc disease. This product, known as Injectable Discosphere Cell Therapy (IDCT), features Discgenics' patented, allogeneic, human disc-derived stem cell technology. The study showed that after one injection of IDCT in degenerated discs there was a restoration of disc height and tissue architecture, while noting no inflammatory response.

Discgenics CEO Flagg Flanagan said, " We are very encouraged by the results of the small animal pilot study as it shows the initial safety and efficacy of IDCT, which is produced from adult human disc-derived stem cells.We are optimistic that these early results will be indicative of our therapy's performance in further animal studies and will accelerate us toward human clinical studies and, ultimately, to an FDA cleared product.We believe this technology will revolutionize the way back pain is treated." Discgenics is currently conducting further studies of safety and efficacy in multiple animal species to support future scientific publications and for use in gaining regulatory clearance.

About Discgenics, Inc.

Discgenics is a privately funded spinal therapeutics company that is utilizing adult human disc stem cells within a tissue engineering approach to treat patients debilitated by degenerative disc disease. News and other information on the company are available at: http://www.discgenics.com.

Read the original:
Discgenics Successfully Completes Pilot Efficacy Study of Injectable Discosphere™ Cell Therapy

Recommendation and review posted by Bethany Smith

Sixty years ago, scientists first discovered DNA, the structure in which a persons genes are encoded. Since then, our knowledge of the genome has revolutionized medicine. But when it comes to the U.S. legal system, important questions about what a gene is remain unsolved.

Here's one question: If a gene is patentable, does that mean a company can claim the rights to the gene's offspring?

The U.S. patent law was written in 1793, and it certainly didnt take into consideration a biological invention that could make endless copies of itself. So when Vernon Bowman, a 75-year-old farmer, decided to save some cash and buy seeds from a bulk grain distributor (seeds that were arguably protected by a patent), did he break intellectual property law?

Here's another: Do law enforcement need a search warrant to take a sample of a person's DNA? When the state of Maryland swabbed the cheek cells of Alonzo King when he was booked for assault, were they violating his Fourth Amendment right to privacy, since those cells would be crucial in convicting him of a crime committed six years earlier? To what extent is DNA protected private information?

As is often the case, U.S. law has still not caught up to the science. Three cases coming before the Supreme Court this term will have a significant impact on the future of genetics and the law. Each contains its own powerful question about genetics and what it means to criminal justice and industry.

Flickr/CodonAUG

Defining a gene can be difficult, but in the broadest sense its easyits a packet of information, says Dr. James P. Evan, a professor of genetics and medicine at the University of North Carolina. And if you have not really changed the content of that, the informational content, you dont deserve a patent.

Because Chakrabarty had actually created something novel, he won the case. But he was dealing in bacterial genetics. The question gets a little more confusing when it comes to human DNA, as well find in the upcoming case Association for Molecular Pathology v. Myriad Genetics.

Heres the background. If youre a woman, you really dont want to have the genes BRCA1 or BRCA2. That because 60 percent of female BRCA carriers develop breast cancer during their lifetime (compared with 12 percent of women in the population at large).

Myriad Genetics found a way to isolate the BRCA genes for testing, and have patented that technology. But they took the patent a step further. Claiming that they altered the BRCA genes to a degree not found in naturethat is, took them outside of a strand of DNAthey also filed a patent on the genes themselves.

More:
What Is a Gene And How Does it Apply to the Law? The Supreme Court Still Doesn't Know

Recommendation and review posted by Bethany Smith

Panel Discussion (Debate) Rehersal
Panel Discussion Topic: Genetic Engineering: Say No or Say Go?

By: Premo C.

Original post:
Panel Discussion (Debate) Rehersal - Video

Recommendation and review posted by Bethany Smith

Genetics and Genetic Engineering
In this live Grade 12 Life Sciences show we take a close look at Genetics Genetic Engineering. In this lesson we discuss inheritance of sex as well as haemophilia colour blindness as sex-linked characteristics. We look at the interpretation of pedigree diagrams and the importance of genetic engineering in medicine agriculture. Finally we discuss related ethics legislation as well as beliefs, attitudes values concerning genetic diseases. Download the Show Notes: http://www.mindset.co.za Visit the Learn Xtra Website: http://www.learnxtra.co.za View the Learn Xtra Live Schedule http://www.learnxtra.co.za Join us on Facebook: http://www.facebook.com Follow us on Twitter: twitter.com ( E00197263 )

By: MindsetLearn

Read the original here:
Genetics and Genetic Engineering - Video

Recommendation and review posted by Bethany Smith

Public release date: 28-Feb-2013 [ | E-mail | Share ]

Contact: Bill Schappert bschappert@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, February 28, 2013Sexting, the use of technology to send or receive sexually explicit messages, photos, or videos, is a relatively new trend and, in many cases, has legal implications. As many as 25-50% of young people may participate in sexting. A close-up look at the sexting practices of a group of urban ethnic minority youths is presented in an article in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available online on the Cyberpsychology, Behavior, and Social Networking website.

In fact, sexting is relatively common among ethnic minority youth, according to Melissa Fleschler Peskin, PhD and coauthors, University of Texas Health Science Center at Houston, School of Public Health. They calculated the prevalence of sexting based on data collected from more than 1,000 tenth graders from a large urban school district. They reported that 20% of students reported sending a nude or semi-nude picture or video or a sexual text messageany one of these considered a "sext"and more than 30% reported receiving a sext.

Additional, sexts were often shared with unintended recipients, and one-third of the youths reported sharing or receiving sexts that were meant to be private.

"In the relatively new discipline of cyberpsychology, we seek to explore the many challenges of current behavior that social networking potentiates. Certainly, such research enables us to better prepare for the behavioral changes that advances in Internet technology will continue to bring," says Brenda K. Wiederhold, PhD, MBA, BCIA, Editor-in-Chief of Cyberpsychology, Behavior, and Social Networking, from the Interactive Media Institute, San Diego, CA.

###

About the Journal

Cyberpsychology, Behavior, and Social Networking is a peer-reviewed journal published monthly online with Open Access options and in print that explores the psychological and social issues surrounding the Internet and interactive technologies, plus cybertherapy and rehabilitation. Complete tables of content and a sample issue may be viewed on the Cyberpsychology, Behavior, and Social Networking website.

About the Publisher

Original post:
How common is 'sexting' among urban minority youth?

Recommendation and review posted by Bethany Smith

Public release date: 1-Mar-2013 [ | E-mail | Share ]

Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, March 1, 2013Most adults and children with type 1 diabetes are not in optimal glycemic control, despite advances in insulin formulations and delivery systems and glucose monitoring approaches. Critical barriers to optimal glycemic control remain. A panel of experts in diabetes management and research met to explore these challenges, and their conclusions and recommendations for how to improve care and optimize clinical decision-making are presented in a white paper in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The paper is available free on the Diabetes Technology & Therapeutics website at http://www.liebertpub.com/dia.

Lead author Richard Bergenstal, MD, International Diabetes Center at Park Nicollet (IDC), outlines the critical issues impacting diabetes management as identified by the panel of luminaries in the field of diabetes during meetings facilitated by the IDC and funded by the Helmsley Charitable Trust. The team of authors emphasizes the critical need for standardization in the collection, reporting, visualization, and analysis of glucose monitoring data, and proposes clear and practical recommendations for implementing these solutions.

The expert panel included DTT Editor-in-Chief Satish Garg, MD, DTT Senior Editor Irl Hirsch, MD, and Andrew Ahmann, MD, Timothy Bailey, MD, Roy Beck, MD, PhD, Joan Bissen, Bruce Buckingham, MD, Larry Deeb, MD, Robert Dolin, MD, Robin Goland, MD, David Klonoff, MD, Davida Kruger, MSN, Glenn Matfin, MB ChB, MSc, Roger Mazze, PhD, Beth Olson, BAN, RN, Christopher Parkin, MS, Anne Peters, MD, Margaret Powers, PhD, Henry Rodriguez, MD, Phil Southerland, Ellie Strock, ANP-BC, William Tamborlane, MD, and David Wesley.

"Glucose monitoring is an essential part of effective diabetes management, and although it has come a long way, both health care providers and patients are frustrated that glucose data reporting has not been standardized," says Satish Garg, MD, Editor-in-Chief of the Journal and Professor of Medicine and Pediatrics at the University of Colorado Denver. "The recommendations reported in this white paper are a good first step toward improving health care outcomes in type 1 diabetes."

The white paper is accompanied by three Commentaries: one by DTT Editor-in-Chief Satish Garg, MD, one by Francine Ratner Kaufman, MD, Medtronic and Children's Hospital, Los Angeles, and one by Aaron Kowalski, PhD and Sanjoy Dutta, PhD, Juvenile Diabetes Research Foundation.

###

About the Journal

Diabetes Technology & Therapeutics is a monthly peer-reviewed journal that covers new technology and new products for the treatment, monitoring, diagnosis, and prevention of diabetes and its complications. Led by Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver, the Journal covers topics that include noninvasive glucose monitoring, implantable continuous glucose sensors, novel routes of insulin administration, genetic engineering, the artificial pancreas, measures of long-term control, computer applications for case management, telemedicine, the Internet, and new medications. Tables of content and a sample issue may be viewed on the Diabetes Technology & Therapeutics website at http://www.liebertpub.com/dia.

Read this article:
New guidelines for standardizing glucose reporting and optimizing clinical decision making in diabetes

Recommendation and review posted by Bethany Smith

Just a Friend Parody with biology lesson
This is a rap about biology to the beat of Biz Markie #39;s Just A Friend. We made this for extra credit in our biology class. Isn #39;t learning about genetics fun? 🙂

By: C-Ziggy Wiggy

Read more:
Just a Friend Parody with biology lesson - Video

Recommendation and review posted by Bethany Smith